Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. For more information, please visit http://jouncetx.com/
As a key member of the Clinical Operations team, this successful candidate will work closely with the Vice President of Clinical Operations and will be responsible for leading the activities in the preparation, implementation, and completion of various clinical trials in accordance with the Development Plan.
This position also provides an opportunity to join a growing development organization and contribute substantially to how the company will operationalize novel immunotherapy oncology trials in the future. In addition, there is an opportunity to expand your knowledge in the scientific and research aspects of immunotherapy in oncology through day-to-day activities and close interactions with the Translational Sciences, Research and Discovery teams within Jounce.
Please apply at https://careers-jouncetx.icims.com/